Publications in collaboration with researchers from Universidad Autónoma de Madrid (8)

2024

  1. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1647-1663

  2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  2. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 193-195

  3. Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation

    The European respiratory journal, Vol. 61, Núm. 2

2022

  1. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

2014

  1. Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: Prevalence, factors and follow-up: The FUNGI-COPD study

    Respiratory Research, Vol. 15, Núm. 1

1991

  1. Chronic community acquired pneumonia due to Klebsiella pneumoniae and Escherichia coli [3]

    Enfermedades Infecciosas y Microbiologia Clinica